Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy